الفهرس Only 14 pages are availabe for public view
 |  | from | 255 |  |  |
| | | from | 255 | | |
Abstract
Cervical cancer and precancerous lesions of the genital tract are
major threats to the health of women worldwide. The introduction of
screening tests to detect cervical cancer precursor lesions has reduced
cervical cancer rates in the developed world, but not in developing
countries. Human papillomavirus (HPV) is the primary aetiologic agent
of cervical cancer and precancerous lesions. Thus, cervical cancer and
other HPV-associated malignancies might be prevented or treated by
HPV vaccines. Two vaccine strategies have been developed.